HMA - Heads of Medicines Agencies
  • RSS
  • Sitemap
  • Contact
  • About HMA
  • Human Medicines
  • Veterinary Medicines
  • You are here:
  • Home
  • >Human Medicines
  • >CMDh
  • >Falsified Medicines
  • CMDh
    • About CMDh
    • Statistics
    • Agendas and Minutes
    • Press Releases
    • BREXIT
    • Procedural Guidance
    • CMDh-Referrals
    • Product Information
    • Advice from CMDh
    • Templates
    • CMD Working Parties / Working Groups
    • Paediatric Regulation
    • Pharmacovigilance
    • Falsified Medicines
    • IGDRP
    • Questions & Answers
    • Contact Points
    • What's new history
  • MRI Product Index
  • Pharmacovigilance
  • Publications and reports
  • National Contacts

  • CMDh clarifications on questions received on the implementation of the Falsified Medicines Directive 
    (March 2017)
  • Implementation plan for the introduction of the safety features on the packaging of nationally authorised medicinal products for human use (February 2016)
    (Due to time constrains, CMDh Safety Features Implementation Guidance for NAPs may need further discussion in upcoming CMDh meetings)
  • Useful Links
  • Privacy Policy
  • Credits & Disclaimer
  • Contact
© Heads of Medicines Agencies - http://www.hma.eu/489.html